| Dr Carl Wilson, MD | |
|
435 Doyle Park Dr, Santa Rosa, CA 95405-4515 | |
| (707) 527-9510 | |
| (707) 527-1306 |
| Full Name | Dr Carl Wilson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 435 Doyle Park Dr, Santa Rosa, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033110465 | NPI | - | NPPES |
| 00G443180 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | G44318 (California) | Primary |
| Entity Name | Providence Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses - and to lead the state's economic recovery - approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies.
New preliminary data from a pilot study in the Netherlands indicates that imaging tools may help address the most challenging clinical dilemma of prostate cancer care as identified by the hearing of the House Oversight and Government Reform Committee and its expert witnesses last week: to treat or not treat, AdMeTech Foundation's President and CEO Dr. Faina Shtern said today.
Air pollution impairs the function of blood vessels in the lungs, according to a study in more than 16 000 patients presented today at EuroEcho-Imaging 2016.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Research findings, an easy-to-read summary, a policy brief and series of video interviews with people with learning disability who co-created and delivered the Who's Challenging Who training project are published today by the University of Warwick's Centre for Educational Development, Appraisal and Research.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carl Wilson, MD 435 Doyle Park Dr, Santa Rosa, CA 95405-4515 Ph: (707) 527-9510 | Dr Carl Wilson, MD 435 Doyle Park Dr, Santa Rosa, CA 95405-4515 Ph: (707) 527-9510 |
News Archive
The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses - and to lead the state's economic recovery - approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies.
New preliminary data from a pilot study in the Netherlands indicates that imaging tools may help address the most challenging clinical dilemma of prostate cancer care as identified by the hearing of the House Oversight and Government Reform Committee and its expert witnesses last week: to treat or not treat, AdMeTech Foundation's President and CEO Dr. Faina Shtern said today.
Air pollution impairs the function of blood vessels in the lungs, according to a study in more than 16 000 patients presented today at EuroEcho-Imaging 2016.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Research findings, an easy-to-read summary, a policy brief and series of video interviews with people with learning disability who co-created and delivered the Who's Challenging Who training project are published today by the University of Warwick's Centre for Educational Development, Appraisal and Research.
› Verified 5 days ago
Rajveer Sangera, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 500 Doyle Park Dr Ste G04, Santa Rosa, CA 95405 Phone: 707-576-7100 | |
Dr. Yulia Rivelis, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3883 Airway Dr, Santa Rosa, CA 95403 Phone: 707-573-5458 Fax: 707-573-5458 | |
Soheila Benrazavi, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4730 Hoen Ave, Santa Rosa, CA 95405 Phone: 707-528-1616 | |
Jarrod Paul Holmes, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3555 Round Barn Cir, Santa Rosa, CA 95403 Phone: 707-528-1050 Fax: 707-525-3874 | |
Dominic Joseph Picetti, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 30 Mark West Springs Rd, Santa Rosa, CA 95403 Phone: 707-576-4000 | |
Parul Kohli, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3536 Mendocino Ave, Ste 300, Santa Rosa, CA 95403 Phone: 707-546-2180 Fax: 707-546-2188 | |
Scott M. Trahms, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 |